SCHEMBL18409672

SCHEMBL18409672

Fc1cccc(-c2nc(CN3CCC(c4cccc(C(F)(F)F)c4)CC3)[nH]c2-c2cc(F)cc(-c3cc(F)cc(-c4nc(CN5CCN(Cc6ccccc6)CC5)[nH]c4-c4cccc(F)c4)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.46
DRD2 P14416 4/20 0.44
DRD4 P21917 2/20 0.44
GRM2 Q14416 1/20 0.44
CNR2 P34972 2/20 0.40
TRPV6 Q9H1D0 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CCR5 P51681 1/20 0.40
CNR1 P21554 1/20 0.40
MAPK14 Q16539 1/20 0.39
TLR9 Q9NR96 1/20 0.39
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
XBP1 P17861 1/20 0.39
HTT P42858 1/20 0.39
BLM P54132 1/20 0.39
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409660 0.91 DRD2 (0.48) CHRM4DRD2DRD4GRM2CNR2
SCHEMBL18409662 0.82 DRD2 (0.47) DRD2DRD4SMN1; SMN2KDM4EMAPK14
SCHEMBL18409293 0.81 CASP1 (0.43) DRD2DRD4KDM4EMAPK14ALDH1A1
SCHEMBL18409622 0.77 DRD2 (0.51) DRD2DRD4SMN1; SMN2KDM4EMAPK14
SCHEMBL9667283 0.76 CHRM4 (0.69) CHRM4DRD2DRD4GRM2TRPV6
SCHEMBL18409305 0.73 DRD4 (0.51) DRD2DRD4SMN1; SMN2MAPK14LMNA
SCHEMBL18409491 0.72 OPRL1 (0.57) CHRM4DRD2DRD4TRPV6SMN1; SMN2
SCHEMBL18409471 0.72 MAPK13 (0.49) KDM4EMAPK14LMNAPOLBSIGMAR1
SCHEMBL18409352 0.72 DRD4 (0.46) DRD2DRD4SMN1; SMN2KDM4ELMNA
SCHEMBL18409624 0.71 ALDH1A1 (0.49) DRD2DRD4KDM4ELMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017011920-A1 COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCERS AND OTHER MEDICAL CONDITIONS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-01-26 WO disclosed